Observation of Bevacizumab intravitreal injection combined with compound trabeculectomy for NVG
Journal Title: Guoji Yanke Zazhi - Year 2018, Vol 18, Issue 7
Abstract
AIM: To observe the efficacy of Bevacizumab intravitreal injection combined with compound trabeculectomy in the treatment of neovascular glaucoma(NVG). <p>METHODS: The 36 eyes were with bevacizumab intravitreal injection 1wk before surgery, and then were treated with trabeculectomy combined with mitomycin. The visual acuity, intraocular pressure, follicle, anterior chamber, regression of iris neovascularization, the number of anti-glaucoma drugs used and others were observed before injection, 1d after intravitreal injection, 1, 3, 6, and 12mo after surgery, respectively. <p>RESULTS: Total success was achieved in 26 eyes, partial success in 7 eyes and failure in 3 eyes at 1a after surgery. The IOP of 1mo(18.183±6.993mmHg), 3mo(19.586±6.198mmHg), 6mo(18.722±5.263mmHg)and 12mo(19.089±4.133mmHg)after surgery were significantly lower than those before injection(39.997±5.827mmHg)and 1d after injection(39.647±5.690mmHg; all <i>P</i><0.05). The IOP of 1mo and 6mo after surgery was significantly lower than that of 3mo after surgery, and the difference was statistically significant(<i>P</i><0.05). There was no statistically significant difference between the other two time points postoperatively(all <i>P</i>>0.05). The LogMAR visual acuity of 1mo(0.686±0.202), 3mo(0.622±0.157), 6mo(0.631±0.179)and 12mo(0.711±0.177)after surgery were significantly higher than that before injection(0.833±0.207)and 1d after injection(0.806±0.188), and the differences were statistically significant(all <i>P</i><0.05). The LogMAR visual acuity of 3mo and 6mo after surgery were significantly higher than that of 1mo after surgery(all <i>P</i><0.05). The LogMAR visual acuity of 12mo after surgery was significantly worse than that of 3mo and 6mo after surgery(all <i>P</i><0.05). There was a significant difference in the number of anti-glaucoma drugs used before and after treatment with this method(<i>t</i>=11.131, <i>P</i><0.05). <p>CONCLUSION: The bevacizumab intravitreal injection combined with compound trabeculectomy is effective in the treatment of NVG.
Authors and Affiliations
Bing Wu
Keywords
Related Articles
- EP ID EP555561
- DOI 10.3980/j.issn.1672-5123.2018.7.38
- Views 122
- Downloads 0
Efficacy of 23G minimally invasive system combined with phacoemulsification for cataract complicated with vitreoretinopathy
AIM: To observe the efficacy of 23G minimally invasive system combined with phacoemulsification in the treatment of cataract complicated with vitreoretinopathy. <p>METHODS: Totally 96 cases(103 eyes)of patients with cata...
Effects of photodynamic therapy with Ranibizumab on visual acuity and postoperative complications in patients with PCV complicated with vitreous hemorrhage
AIM:To explore the photodynamic therapy(PDT)combined with intravitreal injection of Ranibizumab(IVR)on visual acuity, central macular thickness(CMT)and postoperative complications in the treatment of polypoidal choroidal...
Observation of cataract extraction and vitrectomy with gas tamponade for idiopathic macular hole at different stages
AIM: To investigate the visual acuity after cataract extraction and vitrectomy with gas tamponade for idiopathic macular hole(IMH)at different stages. <p>METHODS: In this study, 75 IMH patients(75 eyes)treated in our hos...
Application of optical coherence tomography in maculopathy of high myopia
AIM: To investigate the value of optical coherence tomography(OCT)in maculopathy of high myopia. <p>METHODS: Totally 50 patients(50 affected eyes)with high myopia who were admitted to our hospital during the period from...
Clinical effect and cost analysis of panretinal photocoagulation combined with Ranibizumab or triamcinolone acetonide for diabetic macular edema
AIM: To compare clinical effects and cost of panretinal photocoagulation(PRP)combined with Ranibizumab or triamcinolone acetonide(TA)for diabetic macular edema(DME). <p>METHODS: Forty-eight patients(48 eyes)with DME and...